Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological Responses After Vaccination for COVID-19 With Comirnaty in Immunosuppressed and Immunocompetent Individuals
NCT04780659Phase 4Completed
- Sponsor
- Karolinska University Hospital
- Start
- Feb 2021
- Primary completion
- Oct 2021
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of tozinameran in coronavirus disease 2019 (COVID-19), sponsored by Karolinska University Hospital. Started Feb 2021; status: completed.
02
Drugs
tozinameran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04780659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04780659.